Health
STAT+: At AACR, a provocative use of CAR-T, Merck’s new thing and cancer’s geography problem
At AACR, a bold use of CAR-T raises hopes and provocative questions about its use in smoldering multiple myeloma.
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views New Be the first to read
Brief read Under 1 min brief 23 words
AI Summary
Researchers at the American Association for Cancer Research (AACR) conference presented a novel application of CAR-T cell therapy in treating smoldering multiple myeloma.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
Part of AACR coverage 3 tracked stories
More from Health
Continue reading recent Health coverage
- The one change that worked: Anxiety had me hiding from the world – then two magic questions set me freeContinue reading
- Scientists overcome key barrier to self-amplifying vaccinesContinue reading
- 5 tips for parents worried about their kids' screen time and online safetyContinue reading
- Republicans and Democrats Find a Unifying Target: Pharmacy Benefit ManagersContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow